Egis Pharmaceuticals PLC
Egis Pharmaceuticals PLC (Hungary) holds 3 active US FDA Type II Drug Master Files and 30 inactive, has DMF or CEP filings on record for 36 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Egis Pharmaceuticals PLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/egis-pharmaceuticals-plc
Overview
Egis Pharmaceuticals PLC is a leading pharmaceutical company based in Hungary, known for developing and manufacturing high-quality generic drugs and active pharmaceutical ingredients. The company serves a wide range of therapeutic areas and is committed to innovation and quality in the healthcare industry.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Egis Pharmaceuticals PLC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Egis Pharmaceuticals PLC holds 3 active (33 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- ABEMACICLIB USPActive2026-03-27
- ETHACRYNIC ACIDActive2004-02-26
- PROMETHAZINE HCLActive1989-01-24
- BUTAMINE HYDROCHLORIDE DRUG SUBSTANCE INTERMEDIATEInactive2014-02-28
- AMLODIPINE BESYLATE APIInactive2014-01-31
- ROSUVASTATINInactive2010-02-26
- DERAMCICLANE FUMARATEInactive2002-01-17
- TAMOXIFEN CITRATE BULKInactive2000-10-31
- CHLORAMPHENICOLInactive1998-09-01
- LEVODOPA USP BULKInactive1997-05-15
- BUSPIRONE HYDROCHLORIDE USP BULKInactive1997-02-03
- DOBUTAMINE HYDROCHLORIDEInactive1993-02-11
- PROCHLORPERAZINE MALEATEInactive1991-10-01
- CAPTOPRILInactive1991-07-03
- SULFAMETHOXAZOLEInactive1991-05-30
- NIFEDIPINEInactive1990-10-18
- CHLORPROMAZINE BASEInactive1990-07-30
- SODIUM CROMOGLYCATEInactive1990-06-25
- CLOMIPHENE CITRATE TABLETSInactive1989-10-16
- CARBIDOPAInactive1989-08-28
- IMIPRAMINE HYDROCHLORIDEInactive1989-03-02
- PIROXICAMInactive1988-07-14
- LACTA FACTORY LOCATED IN KORMEND, HUNGARYInactive1988-05-11
- ETHACRYNIC ACIDInactive1988-03-30
- AMITRIPTYLINE HYDROCHLORIDEInactive1987-07-17
- PERPHENAZIN BASEInactive1987-07-17
- DIETHYLCARBAMAZINE CITRATE USPInactive1986-11-10
- CLOMIPHENE CITRATE USPInactive1986-09-04
- CHLORPROMAZINE HClInactive1984-11-09
- TAMOXIFEN CITRATEInactive1984-02-13
- ALLOPURINOLInactive1981-02-26
- CYPROHEPTADINE hclInactive1981-02-10
- ALPHA METHYLDOPA USP XIX BULKInactive1978-10-20
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Egis Pharmaceuticals PLC, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Egis Pharmaceuticals PLC in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Egis Pharmaceuticals PLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.